Harvard Bioscience (HBIO) EBITDA Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported EBITDA Margin of 1.75% for Q2 2026, down 2.15 percentage points from 3.90% a year earlier but up 0.90 percentage points from the prior quarter.
Powered by 
Analysis
Harvard Bioscience (HBIO) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Harvard Bioscience's EBITDA Margin came in at 5.87%, up 57.14 percentage points year-over-year; for FY2025, it was -49.26%, down 50.27 percentage points from FY2024.
- EBITDA Margin has a five-year change of -56.95 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 1.00% in FY2024 (-6.94 pp), 7.95% in FY2023 (+7.38 pp), 0.57% in FY2022 (-7.58 pp) and 8.15% in FY2021 (+0.46 pp).
- Five-year quarterly EBITDA Margin spans a low of -220.51% in Q1 2025 and a high of 19.95% in Q2 2022.
- Year over year, EBITDA Margin gained in four of the last eight quarters, with an average year-over-year change of +1.92 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2026 (a gain of 221.35 percentage points); the low point was Q1 2025 (a drop of 218.47 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.85% (Q1 2026), 12.89% (Q4 2025) and 7.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.72 Bn | 236.75 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.89 Bn | 142.32 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 162.78 Bn | 146.59 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 152.59 Bn | 132.01 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 119.68 Bn | 84.93 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 114.12 Bn | 100.23 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 65.64 Bn | 60.41 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 53.61 Bn | 50.76 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.94 Bn | 34.95 Bn | 1.35 Bn | 31.93% |
| 10 | Harvard Bioscience | 36.98 Mn | 7.95 Mn | 12.63 Mn | 3.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93% |
| Mar 31, 2026 | 3.00% |
| Dec 31, 2025 | 15.52% |
| Sep 30, 2025 | 9.12% |
| Jun 30, 2025 | 4.92% |
| Mar 31, 2025 | -219.90% |
| Dec 31, 2024 | 7.61% |
| Sep 30, 2024 | 0.14% |
| Jun 30, 2024 | -0.86% |
| Mar 31, 2024 | -1.75% |
| Dec 31, 2023 | 7.66% |
| Sep 30, 2023 | 3.61% |
| Jun 30, 2023 | 9.00% |
| Mar 31, 2023 | 11.81% |
| Dec 31, 2022 | 5.54% |
| Sep 30, 2022 | -6.52% |
| Jun 30, 2022 | 20.19% |
| Mar 31, 2022 | -16.66% |
| Dec 31, 2021 | 11.17% |
| Sep 30, 2021 | 8.42% |
API Access
Harvard Bioscience EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();